Overview

Comparing Paroxetine and Duloxetine on Cardiovascular Measures

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
This double-blind placebo-controlled trial is designed to test and to compare the cardiovascular profile of paroxetine controlled release (CR) with duloxetine in outpatients with depressive symptoms.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Duke University
Collaborator:
GlaxoSmithKline
Treatments:
Duloxetine Hydrochloride
Paroxetine